Involvement of dorsal hippocampal NMDA-glutamatergic system in anxiety-related behaviors of rats

Neurochemical Journal

Volumn 5, Issue 3, 2011, Pages 194-199

  Solati, J ^a   Salari, A A ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

anxiety; dorsal hippocampus; MK 801; NMDA

Indexed keywords

EID: 80052466631     PISSN: 18197124     EISSN: 18197132     Source Type: Journal    
DOI: 10.1134/S1819712411030081     Document Type: Article

References (28)

1. Kessler, R., Chiu, W., Demler, O., and Walters, E., Arch. Gen. Psychiatry, 2005, vol. 62, p. 617.
2. Greenberg, P., Sisitsky, T., Kessler, R., Finkelstein, S., Berndt, E., Davidson, J., Ballenger, J., and Fyer, A., J. Clin. Psychiatry, 1999, vol. 60, pp. 427-435.
3. Bergink, V., van Megen, and Westenberg, H., Eur. Neuropsychopharmacol., 2004, vol. 14, pp. 175-183.
4. File, S., Kenny, P., and Cheeta, S., Pharmacol. Biochem. Behav., 2000, vol. 66, pp. 65-72.
5. Graeff, F., Guimaraes, F., De Andrade, T., and Deakin, J., Pharmacol. Biochem. Behav., 1996, vol. 54, pp. 129-141.
6. Engin, E. and Treit, D., Behav. Pharmacol., 2007, vol. 18, p. 365.
7. File, S., Gonzalez, L., and Andrews, N., Behav. Neurosci., 1998, vol. 112, p. 352.
8. Clement, Y. and Chapouthier, G., Neurosci. Biobehav. Rev., 1998, vol. 22, pp. 623-633.
9. Kew, J. and Kemp, J., Psychopharmacol., 2005, vol. 179, pp. 4-29.
10. Guimarães, F., Carobrez, A., Aguiar, J., and Graeff, F., Psychopharmacol., 1991, vol. 103, pp. 91-94.
11. Tsai, M., PhD, G., and Coyle, M., Ann. Rev. Med., 1998, vol. 49, pp. 173-184.
12. Amiel, J. and Mathew, S., Cur. Psychiatry, 2007, vol. 9, pp. 278-283.
13. Greenamyre, J. and Porter, R., Neurol., 1994, vol. 44, pp. 7-13.
14. Palucha, A., Tatarczynska, E., Branski, P., Szewczyk, B., Wieronska, J., Klak, K., Chojnacka-Wojcik, E., Nowak, G., and Pilc, A., Neuropharmacol., 2004, vol. 46, pp. 151-159.
15. Cortese, B. and Phan, K., CNS Spectrums, 2005, vol. 10, p. 820.
16. Paxinos, G., The Rat Brain in Stereotaxic Coordinates, San Diego: Elsevier Academic Press, 2007.
17. Degroot, A., Kashluba, S., and Treit, D., Pharmacol. Biochem. and Behav., 2001, vol. 69, pp. 391-399.
18. Pellow, S., Chopin, P., File, S. E., and Briley, M., J. Neurosci. Meth., 1985, vol. 14, pp. 149-167.
19. Pellow, S., Methods. Find. Exp. Clin. Pharmacol., 1986, vol. 8, pp. 557-565.
20. Zarrindast, M., Solati, J., Oryan, S., and Parivar, K., Pharmacol., 2008, vol. 82, pp. 276-284.
21. Solati, J., Zarrindast, M., and Salari, A., Psychiatry Clin. Neurosci., 2010, vol. 64, pp. 634-641.
22. File, S., Kenny, P., and Cheeta, S., Pharmacol. Biochem. Behav., 2000, vol. 66, pp. 65-72.
23. Willetts, J., Clissold, D., Hartman, T., Brandsgaard, R., Hamilton, G., and Ferkany, J., J. Pharmacol. Exp. Ther., 1993, vol. 265, pp. 1055-1062.
24. Linden, A., Shannon, H., Baez, M., Yu, J., Koester, A., and Schoepp, D., Psychopharmacol., 2005, vol. 179, pp. 284-291.
25. Tatarczynska, E., Klodzinska, A., Kroczka, B., Chojnacka-Wójcik, E., and Pilc, A., Psychopharmacol., 2001, vol. 158, pp. 94-99.
26. Wong, E., Knight, A., and Woodruff, G., J. Neurochem., 1988, vol. 50, pp. 274-281.
27. Jardim, M. and Guimaraes, F., Pharmacol. Biochem. Behav., 2004, vol. 79, pp. 541-546.
28. Stephens, D., Meldrum, B., Weidmann, R., Schneider, C., and Grützner, M., Psychopharmacol., 1986, vol. 90, pp. 166-169.